Clinical Trial Update: DOMME Dose Optimization Multicentric Mexican Evaluation [Phase 4]

View source ↗

Summary

Sanofi completed a Phase 4 multicenter dose-optimization study of DOMME for Type 2 diabetes in Mexico. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DOMME

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED